Advanced Cell Technology is a biotechnology company focused on the application of cellular technology in the field of regenerative medicine. The company specializes in developing cellular therapies to treat diseases and conditions impacting tens of millions of people across the globe. ACT is a leader in the field of regenerative medicine, developing stem cell-based technologies – both adult and human embryonic – and other proprietary methods for patient-specific therapies. For more information, visit the company’s Web site at www.advancedcell.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: